This post is from a suggested group
GCC Downstream Processing Market: Trends in Biopharmaceutical Manufacturing and Purification Technologies
The GCC Downstream Processing Market is a burgeoning sector, intrinsically linked to the region's ambitious strategy to diversify its economy and establish a robust local biopharmaceutical manufacturing industry. Downstream processing (DSP) is the critical series of steps—including clarification, purification, and polishing—required to isolate and purify a high-quality therapeutic product (e.g., monoclonal antibodies, vaccines) from the upstream fermentation or cell culture process. Market growth is driven by government investment in bioprocessing infrastructure and the desire to reduce reliance on imported biological drugs.